[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350767-105":59,"doc-detail-350767-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pan-cancer-evaluation-of-the-neutrophil-to-lymphocyte-ratio-as-a-prognostic-marker-across-six-major-solid-tumors","Pan-cancer Evaluation of the Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker Across Six Major Solid Tumors","","Systemic inflammation is increasingly recognized as a key driver of cancer progression and an important determinant of patient outcomes. Using routinely available peripheral blood counts, the study assessed the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) across multiple common malignancies and built a practical model for overall survival risk estimation. A large registry cohort was analyzed with survival and discrimination metrics to derive and internally evaluate an NLR-based nomogram.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-evaluation-of-the-neutrophil-to-lymphocyte-ratio-as-a-prognostic-marker-across-six-major-solid-tumors/350767/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-evaluation-of-the-neutrophil-to-lymphocyte-ratio-as-a-prognostic-marker-across-six-major-solid-tumors/350767.png","ImageObject",300,407,{"name":92,"@type":93},"anakgang17","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study aiming to evaluate?","Question",{"text":112,"@type":113},"The study evaluated whether the neutrophil-to-lymphocyte ratio (NLR) can serve as a prognostic marker for overall survival across six major solid tumors, and developed a practical survival risk model based on routinely available data.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients selected and split for analysis?",{"text":117,"@type":113},"Patients were included from the INSCOC registry, and 14,425 cases of specified cancers were randomly divided into training (10,098) and validation (4,327) sets.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show regarding NLR and survival?",{"text":121,"@type":113},"NLR demonstrated the highest, though modest, discrimination across the six cancers. A threshold of 3.38 identified patients with significantly shorter overall survival, and the association remained significant after multivariable adjustment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350767,1790956123,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},962090883568,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","doi: 10.21873/invivo.14413  \nPan-cancer Evaluation of the Neutrophil-to-Lymphocyte  \nRatio as a Prognostic Marker Across Six Major Solid Tumors  \nGUILAN CAI1, XIAO ZHANG1, HEYANG ZHANG2 and HANPING SHI3  \n1 Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, P. R. China;  \n2 Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, P. R. China; 3Center for Clinical Nutrition and Department of Colorectal Surgery,  \nThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P. R. China  \nAbstract  \nBackground/Aim: Systemic inflammation is increasingly recognized as a key hallmark of cancer progression and an important determinant of patient outcomes, reflecting the balance between tumor-promoting inflammatory activity and anti-tumor immune competence. Using routinely available peripheral blood counts, we evaluated the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) across several common malignancies and developed a pragmatic model for overall survival risk estimation.  \nPatients and Methods: From the INSCOC registry, 14,425 patients with lung, gastric, colorectal, liver, brain, or breast cancer were included and randomly split (10,098/4,327) into training and validation sets. Six inflammation-based indices from neutrophil, lymphocyte, and platelet counts were compared for overall survival (OS) using Harrell’s C-index and time-dependent receiver operating characteristic (ROC) curves. Associations between NLR and OS were tested by Kaplan-Meier curves, restricted cubic splines, and multivariable Cox models adjusted for demographic, clinical, and treatment factors. A nomogram incorporating NLR and selected routinely available clinical variables was developed and internally evaluated by calibration analysis.  \nResults: NLR showed the highest, though modest, discrimination across all six cancers (C-index ~0.53-0.63) . A threshold of 3.38 identified patients with significantly shorter OS in both sets (log-rank p\u003C0.001). The risk increased progressively with higher NLR and remained significant after multivariable adjustment. Associations were broadly consistent across age, sex, comorbidity, and treatment subgroups. The NLR-based nomogram showed generally acceptable calibration for estimating 1-, 3-, and 5-year survival.  \ncontinued  \n. ChiStnaateTeKl:La61b8o6rat38o8ry fo6385r3D, ieg-estivmail:e1H8e6alt38h86, Beiji3853ng@,1C6h3inacom; N; ationand Darl ClHainnical Resping Shi,eaCrech Center fnotrerClifornicaDl igeNusttriivetioDniseasand Deesp,Beartijimnegnt,  \nDr. Heyang Zhang, Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China;  \nof Colorectal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, P.R. China. Tel: +861  \n3802741263, e-mail: [shihp@ccmu.edu.cn](shihp@ccmu.edu.cn)  \nReceived January 9, 2026 | Revised February 21, 2026 | Accepted June 7, 2026  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n©2026 The Author(s) . Published by the International Institute of Anticancer Research.  \nConclusion: Elevated NLR independently signals worse survival across several major solid tumorsand showed higher prognostic discrimination than other evaluated inflammation-derived indices. The proposed nomogram may provide a simple, clinically applicable tool to support individualized risk stratification using routinely available data.  \nKeywords: Neutrophil-to-lymphocyte ratio, systemic inflammation, cancer prognosis, nomogram, overall survival.  \nIntroduction  \nCancer remains one of the leading causes of morbidity and mortality worldwide, with its incidence continuing to rise despite advances in early detection and therapy (1) . According to the Global Cancer Observatory (GLOBOCAN 2020), lung, colorectal, l","cbCaiaIkPUZkvCcZ","https://ap.wps.com/l/cbCaiaIkPUZkvCcZ","pdf",4621362,"English","# Abstract\n## Background/Aim\n## Patients and Methods\n## Results\n## Conclusion\n# Keywords\n# Introduction\n## Systemic inflammation and cancer progression\n## Rationale for NLR as a prognostic marker","[{\"question\":\"What was the study aiming to evaluate?\",\"answer\":\"The study evaluated whether the neutrophil-to-lymphocyte ratio (NLR) can serve as a prognostic marker for overall survival across six major solid tumors, and developed a practical survival risk model based on routinely available data.\"},{\"question\":\"How were patients selected and split for analysis?\",\"answer\":\"Patients were included from the INSCOC registry, and 14,425 cases of specified cancers were randomly divided into training (10,098) and validation (4,327) sets.\"},{\"question\":\"What did the results show regarding NLR and survival?\",\"answer\":\"NLR demonstrated the highest, though modest, discrimination across the six cancers. A threshold of 3.38 identified patients with significantly shorter overall survival, and the association remained significant after multivariable adjustment.\"}]","Pan-cancer Evaluation of the Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker Across Six Major Solid Tumors | PDF",1790090985,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27adfd88cb38ede03b93ee613cc86445.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0a86fbfc527d29a4bd2281843d77ad0.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0482dee2da48561d7fdfe0e7010cf865.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a1b9ce7f20ca0adb9a5d1934821cbe7.webp",980,1306]